Helsinn

Lugano, CH · 1 known investors

Helsinn is a global pharmaceutical company that develops, manufactures, and commercializes products for patients with cancer and chronic diseases, with a focus on supportive care, oncology, and dermato-oncology. The company operates across 90 countries with direct presence in the U.S., manufacturing in Ireland, and offices in China.